Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Ocular Drug Delivery Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Ocular Drug Delivery Market Status and Forecast (2016-2027)
      • 1.3.2 Global Ocular Drug Delivery Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Ocular Drug Delivery Supply by Company

    • 2.1 Global Ocular Drug Delivery Sales Volume by Company
    • 2.2 Global Ocular Drug Delivery Sales Value by Company
    • 2.3 Global Ocular Drug Delivery Price by Company
    • 2.4 Ocular Drug Delivery Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Ocular Drug Delivery Market Status by Category

    • 3.1 Ocular Drug Delivery Category Introduction
      • 3.1.1 Ocular Insert
      • 3.1.2 Iontophoresis
      • 3.1.3 Intraocular Implants
      • 3.1.4 In Situ Gel & Punctal Plugs
      • 3.1.5 Others
    • 3.2 Global Ocular Drug Delivery Market by Category
      • 3.2.1 Global Ocular Drug Delivery Sales Volume by Category (2016-2021)
      • 3.2.2 Global Ocular Drug Delivery Sales Value by Category (2016-2021)
      • 3.2.3 Global Ocular Drug Delivery Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Ocular Drug Delivery Market Status by End User/Segment

    • 4.1 Ocular Drug Delivery Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Ambulatory Surgical Centers
      • 4.1.3 Ophthalmic Clinics
      • 4.1.4 Homecare Settings
    • 4.2 Global Ocular Drug Delivery Market by End User/Segment
      • 4.2.1 Global Ocular Drug Delivery Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Ocular Drug Delivery Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Ocular Drug Delivery Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Ocular Drug Delivery Market Status by Region

    • 5.1 Global Ocular Drug Delivery Market by Region
      • 5.1.1 Global Ocular Drug Delivery Sales Volume by Region
      • 5.1.2 Global Ocular Drug Delivery Sales Value by Region
    • 5.2 North America Ocular Drug Delivery Market Status
    • 5.3 Europe Ocular Drug Delivery Market Status
    • 5.4 Asia Pacific Ocular Drug Delivery Market Status
    • 5.5 Central & South America Ocular Drug Delivery Market Status
    • 5.6 Middle East & Africa Ocular Drug Delivery Market Status

    6 North America Ocular Drug Delivery Market Status

    • 6.1 North America Ocular Drug Delivery Market by Country
      • 6.1.1 North America Ocular Drug Delivery Sales Volume by Country (2016-2021)
      • 6.1.2 North America Ocular Drug Delivery Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Ocular Drug Delivery Market Status

    • 7.1 Europe Ocular Drug Delivery Market by Country
      • 7.1.1 Europe Ocular Drug Delivery Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Ocular Drug Delivery Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Ocular Drug Delivery Market Status

    • 8.1 Asia Pacific Ocular Drug Delivery Market by Country
      • 8.1.1 Asia Pacific Ocular Drug Delivery Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Ocular Drug Delivery Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Ocular Drug Delivery Market Status

    • 9.1 Central & South America Ocular Drug Delivery Market by Country
      • 9.1.1 Central & South America Ocular Drug Delivery Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Ocular Drug Delivery Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Ocular Drug Delivery Market Status

    • 10.1 Middle East & Africa Ocular Drug Delivery Market by Country
      • 10.1.1 Middle East & Africa Ocular Drug Delivery Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Ocular Drug Delivery Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Ocular Drug Delivery Manufacturing Cost Analysis
    • 11.5 Ocular Drug Delivery Sales Channel and Distributors Analysis
      • 11.5.1 Ocular Drug Delivery Sales Channel
      • 11.5.2 Ocular Drug Delivery Distributors
    • 11.6 Ocular Drug Delivery Downstream Major Buyers

    12 Global Ocular Drug Delivery Market Forecast by Category and by End User/Segment

    • 12.1 Global Ocular Drug Delivery Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Ocular Drug Delivery Forecast by Category
      • 12.2.1 Global Ocular Drug Delivery Sales Volume Forecast by Category
      • 12.2.2 Global Ocular Drug Delivery Sales Value Forecast by Category
      • 12.2.3 Global Ocular Drug Delivery Price Forecast by Category
    • 12.3 Global Ocular Drug Delivery Forecast by End User/Segment
      • 12.3.1 Global Ocular Drug Delivery Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Ocular Drug Delivery Sales Value Forecast by End User/Segment
      • 12.3.3 Global Ocular Drug Delivery Price Forecast by End User/Segment

    13 Global Ocular Drug Delivery Market Forecast by Region/Country

    • 13.1 Global Ocular Drug Delivery Market Forecast by Region (2022-2027)
      • 13.1.1 Global Ocular Drug Delivery Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Ocular Drug Delivery Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 OCULAR THERAPEUTIX, INC
      • 14.1.1 Company Information
      • 14.1.2 Ocular Drug Delivery Product Introduction
      • 14.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Valeant Pharmaceuticals International, Inc
      • 14.2.1 Company Information
      • 14.2.2 Ocular Drug Delivery Product Introduction
      • 14.2.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Taiwan Liposome Company
      • 14.3.1 Company Information
      • 14.3.2 Ocular Drug Delivery Product Introduction
      • 14.3.3 Taiwan Liposome Company Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Santen Pharmaceutical
      • 14.4.1 Company Information
      • 14.4.2 Ocular Drug Delivery Product Introduction
      • 14.4.3 Santen Pharmaceutical Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Graybug Vision Inc
      • 14.5.1 Company Information
      • 14.5.2 Ocular Drug Delivery Product Introduction
      • 14.5.3 Graybug Vision Inc Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 EyeGate Pharma
      • 14.6.1 Company Information
      • 14.6.2 Ocular Drug Delivery Product Introduction
      • 14.6.3 EyeGate Pharma Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Envisia Therapeutics
      • 14.7.1 Company Information
      • 14.7.2 Ocular Drug Delivery Product Introduction
      • 14.7.3 Envisia Therapeutics Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Clearside Biomedical
      • 14.8.1 Company Information
      • 14.8.2 Ocular Drug Delivery Product Introduction
      • 14.8.3 Clearside Biomedical Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Allergan, Plc
      • 14.9.1 Company Information
      • 14.9.2 Ocular Drug Delivery Product Introduction
      • 14.9.3 Allergan, Plc Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Alimera Sciences
      • 14.10.1 Company Information
      • 14.10.2 Ocular Drug Delivery Product Introduction
      • 14.10.3 Alimera Sciences Ocular Drug Delivery Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Ocular Drug Delivery market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Ocular Drug Delivery market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Ocular Insert
      Iontophoresis
      Intraocular Implants
      In Situ Gel & Punctal Plugs
      Others

      Segmented by End User/Segment
      Hospitals
      Ambulatory Surgical Centers
      Ophthalmic Clinics
      Homecare Settings

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      OCULAR THERAPEUTIX, INC
      Valeant Pharmaceuticals International, Inc
      Taiwan Liposome Company
      Santen Pharmaceutical
      Graybug Vision Inc
      EyeGate Pharma
      Envisia Therapeutics
      Clearside Biomedical
      Allergan, Plc
      Alimera Sciences
      Buy now